Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/5/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 10/5/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 10/5/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| -2.69% | -5.28% | +58.42% | +65.89% | 68.45B | |
| -0.92% | +7.70% | +12.90% | +93.35% | 61.31B | |
| 0.00% | -0.95% | +20.09% | +99.04% | 55.73B | |
| +0.11% | +2.35% | +13.08% | +109.47% | 47.51B | |
| -2.24% | -2.37% | +18.72% | +37.03% | 44.68B | |
| -2.32% | -10.24% | +168.08% | +778.32% | 38.14B | |
| +2.15% | -0.47% | +22.85% | +56.09% | 35.85B | |
| -2.32% | -5.14% | +75.43% | +60.15% | 33.05B | |
| +2.61% | +5.85% | -36.58% | +406.69% | 25.9B | |
| Average | -0.53% | +2.41% | +39.22% | +189.56% | 46B | |
| Weighted average by Cap. | -0.82% | +2.25% | +39.31% | +162.75% |
Employees
457
